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patients 114 lesions, 38.5±12.8mm, 43.9±19.5mm), EES (88 patients 94 lesions,
34.2±13.8mm, 40.1±14.8mm) and ZES-R (80 patients 88 lesions, 37.1±13.9mm,
42.3±17.3mm) respectively. We conducted follow-up coronary angiogram in all
patients after successful implantation of SES, PES, EES and ZES-R (9, 12, 18, 24, 36
months respectively).
Results: See table for clinical results.
Conclusion: There is a different timing of late catch up phenomenon (late lumen loss)
of SES, PES, EES and ZES-R (SES: 12-18 months, PES: 9-12 months, EES: 12-18
months and ZES-R: 12-24 months) after successful implantation of SES, PES, EES
and ZES-R in patients with chronic total occlusion. Patients treated with SES, EES
and ZES-R showed lesser loss of minimum lumen diameter compared with PES.
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Background: Pre-procedural inflammation may deteriorate uniform vessel healing
after paclitaxel-eluting stents (PES) deployment.
Methods: Fifty-four lesions treated with PES were evaluated with 6-month follow-up
OCT. All lesions were grouped into tertiles according to pre-procedural hs-CRP level:
tertile 1 (<0.05 mg/dl), tertile 2 (0.05-0.16 mg/dl), tertile 3 (>0.16mg/dl). To assess
unevenness of neointima thickness (NIT), neointimal unevenness score (NUS: max
NIT in the cross section (CS) / average NIT of the same CS) was calculated and
averaged for each stent. Longitudinal and circumferential variability of NIT was
evaluated in 3-dimensions by computing mean NIT within 360 equally-spaced radial
sectors for every 1mm CS. To assess longitudinal variability, NIT within the same
sector was corrected from different CS. Longitudinal standard deviation (SD) was
calculated for each sector. The longitudinal SD from each sector was averaged across
the 360 different sectors. For assessing circumferential variability, SD of NIT within
the same CS was calculated and averaged along the long axis direction. (Figure)
Results: Despite similar NIT, tertile 3 group showed significantly a greater NUS with
a greater %uncovered struts than others. There was a significant positive correlation
between pre-procedural hs-CRP and NUS (R=0.67, P<0.001). Longitudinal and
circumferential variability increased along with increased hs-CRP level. The incidence
of thrombus was highest in the tertile 3 group.
Conclusion: Pre-procedural inflammation may play a key role in delayed arterial
healing by deteriorating uniform vessel healing after PES implantation.
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Background: Patients treated for bifurcation lesions are at high risk for clinical
restenosis and stent thrombosis. The e-HEALING registry was designed to capture
clinical data on the use of the Genous™ Bio-engineered R stent™, an Endothelial
Progenitor Cell capturing stent (ECS), in routine clinical practice. In our current
analysis, we investigated the 12-month clinical outcomes in patients treated with an
ECS for a bifurcation lesion.
Methods: The worldwide, prospective, non-randomized e-HEALING registry aimed
to enrol 5000 patients treated for coronary artery disease with ≥1 ECS between October
2005 and October 2007. Clinical follow-up was at 1, 6 and 12 months. The primary
end point was Target Vessel Failure (TVF), defined as cardiac death, myocardial
infarction, or target vessel revascularization (TVR) at 12 months.
Results: A total of 573 patients (11.6%) were treated for at least one bifurcation lesion
and assessed in the current analysis. Baseline characteristics showed a median age of
65 years, 21% diabetics and 36% had unstable angina. A total of 63% of the bifurcation
lesions was located in the LAD and mean stent length was 20.7 mm. At 12-months,
TVF was 12.7% and TVR was 7.5%. Definite or probable stent thrombosis occurred
in 1.7%.
Conclusion: In the e-HEALING registry, coronary bifurcation stenting with an ECS
results in favourable clinical outcomes and low incidences of repeat revascularization
and stent thrombosis.
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Background: It has been reported that stent fracture after drug-eluting stent (DES)
implantation was related to stent thrombosis. However, there is no data available to
evaluate the association between stent fracture and stent thrombosis considering the
stent type. We investigated the relationship between stent fracture and stent thrombosis,
classified by the occurrence time after DES and bare-metal stent (BMS) implantations:
subacute stent thrombosis (SAT); late stent thrombosis (LST); and very late stent
thrombosis (VLST).
Methods: From January 2001 to March 2011, 8802 lesions (5683 patients) were treated
with BMS and 12079 lesions (8365 patients) were treated with DES. In these patients,
we reviewed the lesions with SAT, LST, and VLST. Stent fracture was defined as
apparent strut separation found by coronary angiography. Stent thrombosis was defined
according to the Academic Research Consortium definition.
Results: SAT occurred in 28 lesions (25 patients) after DES implantation and 40 lesions
(34 patients) after BMS implantation. LST occurred in 12 lesions (12 patients) after
DES implantation and 22 lesions (22 patients) after BMS implantation. VLST occurred
in 27 lesions (25 patients) after DES implantation and 17 lesions (17 patients) after
BMS implantation. The figure shows that stent fracture in stent thrombosis was
significantly more often observed after DES implantation than BMS implantation,
especially in LST and VLST. No stent fracture was observed in stent thrombosis after
BMS implantation.
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